Rankings
▼
Calendar
ELAN Q4 2017 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q4 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$754M
Gross Profit
$349M
46.3% margin
Operating Income
$30M
4.0% margin
Net Income
-$162M
-21.4% margin
EPS (Diluted)
$-0.44
QoQ Revenue Growth
+8.2%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
-$60M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$8.9B
Total Liabilities
$1.1B
Stockholders' Equity
$7.8B
Cash & Equivalents
$323M
← FY 2017
All Quarters
Q1 2018 →
